108 related articles for article (PubMed ID: 25220615)
1. ERG positive prostatic cancer may show a more angiogenetic phenotype.
Strzępek A; Kaczmarczyk K; Białas M; Szpor J; Dyduch G; Szopiński T; Chłosta P; Okoń K
Pathol Res Pract; 2014 Dec; 210(12):897-900. PubMed ID: 25220615
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
[TBL] [Abstract][Full Text] [Related]
3. Frequency of ERG-positive prostate carcinoma in Polands.
Kaczmarczyk K; Dyduch G; Białas M; Demczuk S; Szopiński T; Chłosta P; Okoń K
Pol J Pathol; 2013 Oct; 64(3):175-9. PubMed ID: 24166602
[TBL] [Abstract][Full Text] [Related]
4. ERG expression in intraductal carcinoma of the prostate: comparison with adjacent invasive prostatic adenocarcinoma.
Schneider TM; Osunkoya AO
Mod Pathol; 2014 Aug; 27(8):1174-8. PubMed ID: 24406865
[TBL] [Abstract][Full Text] [Related]
5. Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients.
Kimura T; Furusato B; Miki J; Yamamoto T; Hayashi N; Takahashi H; Kamata Y; van Leenders GJ; Visakorpi T; Egawa S
Pathol Int; 2012 Nov; 62(11):742-8. PubMed ID: 23121605
[TBL] [Abstract][Full Text] [Related]
6. Mast cells influence neoangiogenesis in prostatic cancer independently of ERG status.
Miłek K; Kaczmarczyk-Sekuła K; Strzępek A; Dyduch G; Białas M; Szpor J; Gołąbek T; Szopiński T; Chłosta P; Okoń K
Pol J Pathol; 2016; 67(3):244-249. PubMed ID: 28155973
[TBL] [Abstract][Full Text] [Related]
7. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.
Tsourlakis MC; Weigand P; Grupp K; Kluth M; Steurer S; Schlomm T; Graefen M; Huland H; Salomon G; Steuber T; Wilczak W; Sirma H; Simon R; Sauter G; Minner S; Quaas A
Am J Pathol; 2014 Mar; 184(3):609-17. PubMed ID: 24378408
[TBL] [Abstract][Full Text] [Related]
8. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.
Warrick JI; Humphrey PA
Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence.
Tsourlakis MC; Schoop M; Plass C; Huland H; Graefen M; Steuber T; Schlomm T; Simon R; Sauter G; Sirma H; Minner S
Hum Pathol; 2013 Sep; 44(9):1789-96. PubMed ID: 23642739
[TBL] [Abstract][Full Text] [Related]
10. Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistry.
Schelling LA; Williamson SR; Zhang S; Yao JL; Wang M; Huang J; Montironi R; Lopez-Beltran A; Emerson RE; Idrees MT; Osunkoya AO; Man YG; Maclennan GT; Baldridge LA; Compérat E; Cheng L
Hum Pathol; 2013 Oct; 44(10):2227-33. PubMed ID: 23850495
[TBL] [Abstract][Full Text] [Related]
11. ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features: comparison with conventional prostatic adenocarcinoma.
Johnson H; Zhou M; Osunkoya AO
Hum Pathol; 2013 Oct; 44(10):2241-6. PubMed ID: 23849895
[TBL] [Abstract][Full Text] [Related]
12. ERG protein expression in human tumors detected with a rabbit monoclonal antibody.
Yaskiv O; Rubin BP; He H; Falzarano S; Magi-Galluzzi C; Zhou M
Am J Clin Pathol; 2012 Dec; 138(6):803-10. PubMed ID: 23161713
[TBL] [Abstract][Full Text] [Related]
13. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma.
El-Gohary YM; Silverman JF; Olson PR; Liu YL; Cohen JK; Miller R; Saad RS
Am J Clin Pathol; 2007 Apr; 127(4):572-9. PubMed ID: 17369132
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer with different ERG status may show different FOXP3-positive cell numbers.
Kaczmarczyk-Sekuła K; Gałązka K; Glajcar A; Miłek K; Dyduch G; Szpor J; Gołąbek T; Szopiński T; Chłosta P; Rubinkiewicz M; Tyrak K; Okoń K
Pol J Pathol; 2016; 67(4):313-317. PubMed ID: 28547958
[TBL] [Abstract][Full Text] [Related]
15. Computerized whole slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostate tissue.
van Niekerk CG; van der Laak JA; Börger ME; Huisman HJ; Witjes JA; Barentsz JO; Hulsbergen-van de Kaa CA
Prostate; 2009 Jan; 69(1):62-9. PubMed ID: 18780292
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of mutually exclusive expression of ERG and SPINK1 in endocrine-treated prostatic cancer].
Teng L; Gao W; Lu D; Xu J; Zhao L
Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):149-53. PubMed ID: 24842011
[TBL] [Abstract][Full Text] [Related]
17. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31.
de la Taille A; Katz AE; Bagiella E; Buttyan R; Sharir S; Olsson CA; Burchardt T; Ennis RD; Rubin MA
Am J Clin Pathol; 2000 Apr; 113(4):555-62. PubMed ID: 10761458
[TBL] [Abstract][Full Text] [Related]
18. Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays.
Tretiakova M; Antic T; Binder D; Kocherginsky M; Liao C; Taxy JB; Oto A
Hum Pathol; 2013 Apr; 44(4):495-502. PubMed ID: 23069258
[TBL] [Abstract][Full Text] [Related]
19. ERG oncoprotein expression in prostatic acinar adenocarcinoma; clinicopathologic significance.
Hashmi AA; Khan EY; Irfan M; Ali R; Asif H; Naeem M; Nisar L; Faridi N; Khan A; Edhi MM
BMC Res Notes; 2019 Jan; 12(1):35. PubMed ID: 30658688
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of MVD, LVD and vascular invasion in lymph node-negative colon cancer.
Sundov Z; Tomic S; Alfirevic S; Sundov A; Capkun V; Nincevic Z; Nincevic J; Kunac N; Kontic M; Poljak N; Druzijanic N
Hepatogastroenterology; 2013 May; 60(123):432-8. PubMed ID: 23321007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
